申请人:Goedecke Aktiengesellschaft
公开号:US04912107A1
公开(公告)日:1990-03-27
The invention concerns new pyrrolocarbazole derivatives of formula ##STR1## processes for their preparation, as well as medicaments containing these for the inhibition of protein kinases, such as protein kinase C, and thus for the prevention and/or treatment of heart and blood vessel diseases, such as thromboses, arterioscleroses, hypertension, of inflammatory processes, allergies, cancers, and certain degenerative damages of the central nervous system as well as for the treatment of viral diseases.
本发明涉及新的吡咯喹啉类衍生物,其化学式为##STR1##以及制备它们的方法,以及含有这些化合物的药物,用于抑制蛋白激酶,如蛋白激酶C,从而预防和/或治疗心脏和血管疾病,如血栓、动脉硬化、高血压、炎症过程、过敏、癌症以及某些中枢神经系统的退行性损伤,以及治疗病毒性疾病。